75716-69-7

Basic information

• Product Name: dimethyl 2-hydroxy-4-methylbenzene-1,3-dicarboxylate
• Synonyms: dimethyl 2-hydroxy-4-methylbenzene-1,3-dicarboxylate
• CAS NO: 75716-69-7
• Molecular Formula: C₁₁H₁₂O₅
• Molecular Weight: 224.20998
• Mol File: 75716-69-7.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: dimethyl 2-hydroxy-4-methylbenzene-1,3-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: dimethyl 2-hydroxy-4-methylbenzene-1,3-dicarboxylate(75716-69-7)
• EPA Substance Registry System: dimethyl 2-hydroxy-4-methylbenzene-1,3-dicarboxylate(75716-69-7)

Safety Data

• Hazardous Substances Data: 75716-69-7(Hazardous Substances Data)

Upstream product

• 5765-44-6 5-methylisoxazole 
• 1830-54-2 3-oxopentanedioic acid dimethyl ester 
• 625-34-3 3-oxobutyraldehyde 
• 1809-59-2 4-(diethylamino)-3-butene-2-one 
• 1119-19-3 but-2-ynal 
• 1423-60-5 methyl ethynyl ketone 
• 67-64-1 acetone 
• 2976-86-5 1-amino-1-buten-3-one 

Downstream Products

• 83769-04-4 methyl 8-hydroxy-3-methyl-1-oxo-3,4-dihydro-(1H)-2-benzopyran-7-carboxylate 

Relevant articles and documents

One pot synthesis of phenolic compounds from aliphatic ones

Synthesis of tetra and pentasubstituted phenols from dimethyl 1,3- acetonedicarboxilate anion 1 and alkinones 2 is described. The salient feature of this procedure is to provide phenols with regiocontrol at the 3/5 positions.

Syntheses of extreme sterically hindered 4-methoxyboronic acids

4-Iodoanisoles 3a,b, 3d and 4-bromoanisoles 4a-d were readily obtained. An extreme steric hindrance precluded obtaining 3c. Catalytic borylation of 3a,b, 3d followed by hydrolysis of boronic ester 26a,b, 26d easily provided the boronic acids 5a,b, 5d. Com

COMPOUNDS AND COMPOSITIONS USEFUL IN THE TREATMENT OF NEOPLASIA

There is described compounds for use in therapy, said compounds being defined by Formula (1): There is also described an anti-proliferative composition comprising one or more compounds according to Formula (1), and a method of treatment of neoplasia comprising the administration of such a compound or composition.